SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|
Total revenue | -66.71%431.38K | -15.95%1.3M | 69.15%1.54M | 70.32%911.51K | 39.57%535.17K | 383.45K |
Operating revenue | -66.71%431.38K | -15.95%1.3M | 69.15%1.54M | 70.32%911.51K | 39.57%535.17K | --383.45K |
Cost of revenue | -65.39%420.81K | -16.72%1.22M | 43.83%1.46M | 27.75%1.02M | 149.85%794.55K | 318.01K |
Gross profit | -86.80%10.57K | -2.19%80.07K | 179.08%81.85K | 60.09%-103.51K | -496.37%-259.38K | 65.44K |
Operating expense | -38.97%10.73M | -8.81%17.59M | -4.38%19.29M | 12.45%20.17M | 72.60%17.94M | 10.39M |
Selling and administrative expenses | -44.57%4.41M | -0.77%7.97M | 4.14%8.03M | -25.55%7.71M | 53.80%10.35M | --6.73M |
-Selling and marketing expense | -50.06%48.98K | --98.08K | ---- | ---- | --316.23K | ---- |
-General and administrative expense | -44.50%4.37M | -2.00%7.87M | 4.14%8.03M | -23.20%7.71M | 49.10%10.04M | --6.73M |
Research and development costs | -43.62%5.2M | -15.18%9.22M | -6.19%10.87M | 66.98%11.59M | 123.74%6.94M | --3.1M |
Depreciation amortization depletion | -62.51%53.8K | --143.5K | ---- | ---- | --426.38K | ---- |
-Depreciation and amortization | -62.51%53.8K | --143.5K | ---- | ---- | --426.38K | ---- |
Other operating expenses | 309.02%1.07M | -33.50%261.04K | -55.26%392.51K | 297.21%877.39K | -60.61%220.89K | --560.71K |
Operating profit | 38.75%-10.72M | 8.84%-17.51M | 5.27%-19.21M | -11.41%-20.28M | -76.20%-18.2M | -10.33M |
Net non-operating interest income expense | -182.64%-121.15K | 256.61%146.59K | 61.58%-93.6K | 93.41%-243.63K | 17.01%-3.7M | -4.46M |
Non-operating interest expense | ---- | ---- | ---- | -93.41%243.63K | -17.01%3.7M | --4.46M |
Total other finance cost | 182.64%121.15K | -256.61%-146.59K | --93.6K | ---- | ---- | ---- |
Other net income (expense) | 11.43%6.5M | 174.71%5.84M | -130.71%-7.81M | 1,328.23%25.44M | 611.55%1.78M | -348.2K |
Gain on sale of security | 16.33%6.34M | 167.87%5.45M | -132.09%-8.04M | 8,636.27%25.04M | 182.32%286.65K | ---348.2K |
Special income (charges) | --0 | --0 | --71.36K | --0 | --1.2M | --0 |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---1.2M | ---- |
-Gain on sale of business | --0 | --0 | ---3.64K | --0 | --0 | ---- |
-Gain on sale of property,plant,equipment | --0 | --0 | --75K | --0 | --0 | ---- |
Other non- operating income (expenses) | -58.33%159.8K | 153.53%383.51K | -61.88%151.27K | 34.04%396.81K | --296.05K | ---- |
Income before tax | 62.33%-4.34M | 57.49%-11.53M | -651.08%-27.11M | 124.46%4.92M | -32.92%-20.12M | -15.13M |
Income tax | ||||||
Net income | 62.33%-4.34M | 57.49%-11.53M | -651.08%-27.11M | 124.46%4.92M | -32.92%-20.12M | -15.13M |
Net income continuous Operations | 62.33%-4.34M | 57.49%-11.53M | -651.08%-27.11M | 124.46%4.92M | -32.92%-20.12M | ---15.13M |
Minority interest income | 12.12%-1.52M | 16.48%-1.73M | 3.76%-2.07M | -50.10%-2.15M | -372.38%-1.43M | -302.76K |
Net income attributable to the parent company | 71.18%-2.82M | 60.88%-9.8M | -454.45%-25.05M | 137.82%7.07M | -25.99%-18.69M | -14.83M |
Preferred stock dividends | ||||||
Other preferred stock dividends | 755.51K | 0 | 0 | |||
Net income attributable to common stockholders | 71.18%-2.82M | 60.88%-9.8M | -496.88%-25.05M | 133.77%6.31M | -25.99%-18.69M | -14.83M |
Basic earnings per share | 77.45%-0.62 | 61.54%-2.75 | -452.22%-7.15 | 131.72%2.03 | -20.75%-6.4 | -5.3 |
Diluted earnings per share | 77.45%-0.62 | 61.54%-2.75 | -457.50%-7.15 | 131.25%2 | -20.75%-6.4 | -5.3 |
Dividend per share | ||||||
Currency Unit | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- |